NCT02838212已完成不适用
Adverse Drug Reactions With Fatal Outcome
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,135
- 主要终点
- Incidence of drug-related deaths of all hospital admissions
研究概览
简要总结
The purpose of this study is to determine the incidence of drug-related deaths in a university hospital during the year 2015
详细描述
The investigators aimed to determine the incidence of drug-related mortality of admitted patients in a university hospital during the year 2015
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •inpatients deaths and drug-related deaths.
排除标准
- •death patients in the emergency room, patients with a death diagnosis not available, and dead patients due to other causes non-drug related.
研究组 & 干预措施
Drug-related deaths
fatal adverse drug reactions
干预措施: adverse drug reaction (Drug)
结局指标
主要结局
Incidence of drug-related deaths of all hospital admissions
时间窗: during the year 2015
次要结局
- Number of drug-related deaths with autopsy(during the year 2015)
- Number of drug-related deaths with the suspected drug started the previous week(during the year 2015)
- Number of drug-related deaths with drug interactions between suspected drugs(during the year 2015)
- Number of preventable drug-related deaths assessed by Schumock criteria(during the year 2015)
- Number of drug-related deaths with polypharmacy(during the year 2015)
- Incidence of drug-related deaths of all inpatients deaths(during the year 2015.)
- Number of drug-related deaths in which the suspected drug had a contributive role(during the year 2015)
- Number of drug-related deaths with "certain" or "probable" categories assessed by World Health Organization (WHO) criteria and Naranjo algorithm(during the year 2015)
- Risk factors of drug-related deaths(during the year 2015)
- Number of drug-related deaths presented during hospitalization(during the year 2015)
研究者
Eva Montané
Clinical Pharmacologist
Germans Trias i Pujol Hospital
相似试验
Unknown
不适用
Therapeutic Drug Monitoring for Individualized Clozapine TherapySchizophreniaNCT03523741Seoul National University Hospital100
已完成
不适用
Study Evaluating Pharmacovigilance Of Refacto AFHemophilia ANCT00895037Pfizer101
已完成
不适用
Impact of Pharmaceutical Care on Drug-related Problems in Patients With Parkinson's DiseaseParkinson DiseaseNCT05410210Mahidol University80
已完成
不适用
Special Investigation in Patients With Crohn's Disease (All Patients Investigation)Crohn's DiseaseNCT01298648AbbVie (prior sponsor, Abbott)1,716
已完成
不适用
Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)SARS-CoV-2 InfectionNCT05687877AstraZeneca366